Nexalin Technology NXL
NASDAQ NXL
$4.87 -0.18 (-3.56%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) Retained Earnings (2021 - 2026)

Nexalin Technology (NXL) posted Retained Earnings of $98.7 million for Q2 2026, up 0.89% on a QoQ basis from $97.8 million in Q1 2026, and up 4.82% year-over-year from $94.2 million in Q2 2025.

Analysis

Nexalin Technology (NXL) Retained Earnings (2021 - 2026) Analysis & Trends

Nexalin Technology has reported Retained Earnings for 6 years, with the latest figure at $98.7 million in Q2 2026.

  • On a quarterly basis, Retained Earnings rose 4.82% year-over-year to $98.7 million in Q2 2026; TTM through Jun 2026 was $98.7 million, a 4.82% increase from a year earlier, with the FY2025 full-year figure at $96.6 million, up 9.38% from the prior year.
  • Retained Earnings was $98.7 million for Q2 2026 at Nexalin Technology, up from $97.8 million in the prior quarter.
  • The five-year high for Retained Earnings was $98.7 million in Q2 2026, with the low at $77.8 million in Q4 2022.
  • Average Retained Earnings over 5 years is $86.2 million, with a median of $83.7 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Retained Earnings soared 210.09% in 2022, then gained 1.9% in 2023.
  • Over 5 years, Retained Earnings stood at $77.8 million in 2022, then gained by 3.1% to $80.2 million in 2023, then increased by 10.06% to $88.3 million in 2024, then grew by 9.38% to $96.6 million in 2025, then climbed by 2.18% to $98.7 million in 2026.
  • The last three Retained Earnings figures came in at $98.7 million (Q2 2026), $97.8 million (Q1 2026), and $96.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 49.79 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 6.84 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 33.19 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 21.82 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 7.82 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 14.86 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 21.58 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 2.88 Bn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 3.15 Bn
10 Nexalin Technology 3.44 Mn 2.44 Mn 8,897.00 98.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 98.70 Mn
Mar 31, 2026 97.83 Mn
Dec 31, 2025 96.60 Mn
Sep 30, 2025 95.24 Mn
Jun 30, 2025 94.16 Mn
Mar 31, 2025 88.95 Mn
Dec 31, 2024 88.31 Mn
Sep 30, 2024 86.76 Mn
Jun 30, 2024 80.71 Mn
Mar 31, 2024 80.40 Mn
Dec 31, 2023 80.24 Mn
Sep 30, 2023 79.49 Mn
Jun 30, 2023 77.91 Mn
Mar 31, 2023 77.82 Mn
Dec 31, 2022 77.82 Mn
Sep 30, 2022 78.01 Mn
Dec 31, 2021 -70.69 Mn